Cat# : THA-0054
| Cat#: | THA-0054 |
| Product Name: | Obinutuzumab |
| Description: | Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil. |
| Sequences: | Not Available |
| Molecular Weight: | 146100.0 Da |
| Introduction: | Obinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. |
| Purity: | >99% by SDS-Page and HPLC analysis |
| Formula: | C6512H10060N1712O2020S44 |
| Appearance: | Liquid |
| Endotoxin Level: | < 0.001 EU/μg of the protein by the LAL method |
|
|
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2025 Creative BioMart. All Rights Reserved.
